drugset / Trial / NCT05191823
Omega Tots Long Term Follow-up
Enrolling by invitation
377 enrolled
Sarah Keim
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a continuation study to the Omega Tots trial (NCT01576783). The purpose of this study is to follow-up with participants of the original study to determine the long-term effect a daily fatty acid dietary supplement taken during toddlerhood might have on children born preterm now that they are 8.5-10.5 years old.
Timeline
- Start
- 2021-12-01
- Primary completion
- 2024-06-25
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arachidonic Acid | Small molecule | 200 mg | — |
| Subject | DOCONEXENT | Other / unclassified | 200 mg | — |